Keratoprosthesis (KPro) is an artificial cornea intended to restore vision in patients suffering from severe bilateral corneal disease.
Increase in Incidences of Corneal Blindness Likely to Boost Keratoprosthesis (KPro) Market
- Keratoprosthesis (KPro) is an artificial cornea intended to restore vision in patients suffering from severe bilateral corneal disease. There are two types of keratoprosthesis: penetrating keratoprosthesis and non-penetrating keratoprosthesis.
Read Report Overview - https://www.transparencymarketresearch.com/keratoprosthesis-kpro-market.html
- Penetrating keratoprosthesis is indicated in a patient with vision less than 20/200 in the affected eye, patient with failed cornea transplant with donor cornea and has low or no vision, patient with congenital birth defects and other ocular problems, and patient who does not have access to corneal transplant tissue. Non-penetrating keratoprosthesis is indicated in corneal dystrophies, corneal edema, corneal scars, limbal stem cell deficiency, etc.
- Keratoprosthesis is the most common treatment for severe corneal opacity. It is recommended when corneal transplant is not an option.
- Keratoprosthesis indications have expanded significantly over the years and post-operative complications have reduced with modifications in postoperative regimen and design of prosthesis. According to an article published by the Indian Journal of Ophthalmology, the last decade has experienced a surge in the number of keratoprosthesis procedures performed worldwide.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72667
Key Drivers and Restraints of Global Keratoprosthesis (KPro) Market
- Blindness is one of the major public health problems in developing countries. According to the World Health Organization, corneal diseases are majorly responsible for blindness and vision loss after glaucoma and cataract.
- According to the International Agency for the Prevention of Blindness (IAPB), corneal opacity accounts for 3.46% of the global blindness. Corneal opacity is caused by a variety of disorders, including nutritional, congenital, traumatic, infectious, hereditary, and degenerative conditions.
Request for Analysis of COVID-19 Impact on Keratoprosthesis (KPro) Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72667
- Increase in prevalence of corneal blindness and rise in the demand for technologically advanced corneal surgery equipment are anticipated to drive the keratoprosthesis market during the forecast period. Moreover, changes in lifestyle, aging population, and increase in awareness and acceptance of several corneal surgery devices have driven manufacturers to introduce devices that are patient-friendly, portable, and cost effective.
- Keratoprosthesis has evolved over the years due to product enhancement and decline in side effects of keratoplasty. The growth of the ophthalmology industry can be attributed to periodic introduction of novel technologies in the field of ophthalmic surgery. The need and preference for improved health care facilities have created potential for development and commercialization of surgical platforms.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=72667
Biosynthetic Implants to Witness High Demand
- The keratoprosthesis (KPro) market can be categorized on the basis of type of implant, indication, end-user, and region. In terms of type of implant, the keratoprosthesis (KPro) market can be segmented into synthetic implants and biosynthetic implants. On the basis of indication, the keratoprosthesis (KPro) market can be categorized into keratitis, bullous keratopathy, keratoconus, corneal stromal dystrophies, and others.
- Recent studies on the safety and functionality of biosynthetic implants have shown many benefits over conventional implants, such as low manufacturing cost and redundancy of microbiological testing, which is likely to drive the biosynthetic implants segment during the forecast period
- Based on end-user, the keratoprosthesis (KPro) market can be divided into hospitals, ambulatory surgery centers, specialty clinics, and others
Pre Book Keratoprosthesis (KPro) Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=72667<ype=S
Asia Pacific to Lead Global Keratoprosthesis (KPro) Market
- The global keratoprosthesis (KPro) market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is expected to dominate the keratoprosthesis (KPro) market in terms of revenue during the forecast period
- Asia Pacific is likely to witness the maximum demand for the keratoprosthesis (KPro) procedure from 2019 to 2027. High prevalence of corneal blindness, low cost of surgery, and rising health care infrastructure in emerging countries, such as China and India, are likely to drive the keratoprosthesis (KPro) market in the region.
- According to the National Programme for Control of Blindness (NPCB), over 120,000 persons suffer from corneal blindness in India. According to this estimate, more than 25,000 to 30,000 corneal blindness cases are reported every year in the country. Moreover, 90% of the cases of corneal ulceration and ocular trauma leading to corneal blindness are reported in developing countries.
More Trending Reports by Transparency Market Research:
Nephropathic Cystinosis Treatment Market For several decades, researchers, healthcare providers, drug developers, and other participants of the healthcare systems worldwide continue to develop new treatments and drugs for patients suffering from rare and chronic diseases that are complex in nature.
Sterilization Market Sterilization technologies are techniques for removal of all viable life forms such as bacteria, prions, viruses, fungi, and spore from surfaces such as equipment, medicines, drugs, food ingredients, and biological culture medium. Various sterilization techniques and equipment have emerged to enhance sterilization in order to meet the needs of a number of products in various industries.
Acute Kidney Injury Treatment Market Increasing geriatric population, susceptible to acute kidney injury (AKI), has created pressure on researchers and scientists to develop appropriate treatment and therapeutics. Currently, there are around 40 candidate drugs, meant for acute kidney injury treatment, and most of them are in their final stage of approval.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/